Literature DB >> 8651358

Bilateral primary ovarian squamous cell carcinoma associated with human papilloma virus infection and vulvar and cervical intraepithelial neoplasia. A case report with review of the literature.

K T Mai1, H M Yazdi, M A Bertrand, N LeSaux, L L Cathcart.   

Abstract

Primary squamous cell carcinoma of the ovary is rare. Most cases represent malignant transformation of ovarian teratomas. Other cases are associated with preexisting Brenner tumor or ovarian endometriosis. We report a primary ovarian squamous cell carcinoma in a 40-year-old woman. The patient had recurrent high-grade intraepithelial neoplasia of the vulva (VIN) and recurrent high-grade cervical intraepithelial neoplasia (CIN). Human papilloma virus (HPV) DNA 16/18 was identified in an in situ and invasive carcinoma in the left ovary; CIN and VIN were identified with in situ hybridization with biotinylated DNA probes. Review of the literature revealed nine cases of primary ovarian squamous cell carcinoma not associated with a preexisting ovarian lesion. Three cases were not associated with CIN and occurred in women who ranged in age from 64 to 90 years and did not have carcinoma in situ component. Six cases were associated with CIN, had a carcinoma in situ, and occurred in younger women ranging from 33 to 54 of age. Our case belonged to the latter category. This report raises the possible causal relationship of HPV with primary ovarian squamous carcinoma in the group of middle-aged patients with CIN.

Entities:  

Mesh:

Year:  1996        PMID: 8651358     DOI: 10.1097/00000478-199606000-00016

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Synchronous papillary cystadenocarcinoma of ovary and squamous cell carcinoma of lower vagina: first report of an unusual chance occurrence.

Authors:  Shashank Shekhar; Sita Thakur; Kamal Singh; Bal Chander
Journal:  BMJ Case Rep       Date:  2013-01-11

2.  Parvovirus b19 persistence in abnormal thyroid tissue of a mature cystic ovarian teratoma: a case report.

Authors:  Laura A Adamson-Small; Larry J Fowler; Jacqueline A Hobbs
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

3.  Pure primary ovarian squamous cell carcinoma: A case report and review of the literature.

Authors:  Jung-Woo Park; Jong Woon Bae
Journal:  Oncol Lett       Date:  2014-10-31       Impact factor: 2.967

Review 4.  Malignant transformation of ovarian mature cystic teratoma into squamous cell carcinoma: a Taiwanese Gynecologic Oncology Group (TGOG) study.

Authors:  An Jen Chiang; Min Yu Chen; Chia Sui Weng; Hao Lin; Chien Hsing Lu; Peng Hui Wang; Yu Fang Huang; Ying Cheng Chiang; Mu Hsien Yu; Chih Long Chang
Journal:  J Gynecol Oncol       Date:  2017-06-13       Impact factor: 4.401

5.  Long-term recurrence-free survival of a patient with advanced pure primary ovarian squamous cell carcinoma treated with dose-dense paclitaxel combined with carboplatin.

Authors:  Hiroyuki Yazawa; Tsuyoshi Hiraiwa; Fumihiro Ito; Keiya Fujimori
Journal:  Obstet Gynecol Sci       Date:  2017-10-17

6.  Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.

Authors:  Yoshiko Nanki; Tatsuyuki Chiyoda; Fumio Kataoka; Hiroyuki Nomura; Naoki Nakadaira; Naomi Iwasa; Shiho Hashimoto; Hirokazu Arima; Nobuyuki Susumu; Daisuke Aoki
Journal:  J Obstet Gynaecol Res       Date:  2017-03-28       Impact factor: 1.730

Review 7.  Recurrence of ovarian squamous cell carcinoma with MET gene copy number variation: a case report and review of literature.

Authors:  Xuhui Dong; Lei Yuan; Liangqing Yao
Journal:  J Ovarian Res       Date:  2020-05-31       Impact factor: 4.234

Review 8.  Squamous cell carcinoma in mature cystic teratoma of the ovary induced by human papillomavirus 16 infection: A case report and literature review.

Authors:  Zhixian Shi; Lingyun Yang; Ce Bian
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

9.  Detection of human papillomavirus-16 in ovarian malignancy.

Authors:  Q-J Wu; M Guo; Z-M Lu; T Li; H-Z Qiao; Y Ke
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.